Summary
Boehringer Ingelheim Venture Fund
Founded in 2010
Description
The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.
Strengths
- Boehringer Ingelheim Venture Fund has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Since Boehringer Ingelheim Venture Fund was founded, the company has grown faster than the industry average
Annual Revenue
Boehringer Ingelheim Venture Fund's annual revenue
$6835000
Based on Kona Equity data
-
Revenue per employee
$207121
-
Annual revenue growth since founding
$488214
Employee Count
33 employees
Executives
G Score - 3
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
Location
Unlock unlimited leads
Similar Companies
kddsystems.com
kddsystems.com- Location: New York, NY
- Annual Revenue: $1.8M
- Employees: 20
The Column Group
thecolumngroup.com- Location: San Francisco, CA
- Annual Revenue: $2.7M
- Employees: 13
Revitope Oncology
revitope.com- Founded in 2016
- Location: Cambridge, MA
- Annual Revenue: $2.3M
- Employees: 9
- Revitope Oncology is a biotech company leveraging biological insights and protein engineering to develop a new class of cancer immunotherapies powered for precision.
SBH Sciences Inc
sbhsciences.com- Founded in 1997
- Location: Natick, MA
- Annual Revenue: $4.0M
- Employees: 18
- SBH Sciences offers superior biotechnology products and services for Discovery Research. SBH Sciences supports startup companies, entrepreneur scientists, and the biotechnology industry with our experience and expertise to help shorten your timelines a...
Zumutor Biologics
zumutor.com- Founded in 2015
- Location: Cambridge, MA
- Annual Revenue: $5.3M
- Employees: 25
- Zumutor Biologics is a leading Immuno Oncology company specializing in targeted NK cell therapeutics. They have developed a proprietary Human Antibody platform called INABLR, which is the foundation for their therapeutic antibodies. These antibodies t...
Key Information
- Name: Boehringer Ingelheim Venture Fund
- Industry: Venture capital company
- SIC: 28; 283
- NAICS: 32; 325
See similar companies
-
By City Cambridge Small Venture capital company in Cambridge Mid-size Venture capital company in Cambridge
-
By State MA Small companies in MA Small Venture capital company in MA Mid-size Venture capital company in MA
-
By Industry Venture capital company Small Venture capital company Mid-size Venture capital company
-
Firmographic data G Score of 3 Founded in 2010 SIC: 28 SIC: 283 NAICS: 32 NAICS: 325 #Manufacturing #Pharmaceuticals
Frequently Asked Questions
Boehringer Ingelheim Venture Fund's headquarters are located at 6132 77-181170 1 Cambridge, MA 02142.
Boehringer Ingelheim Venture Fund's official website is boehringer-ingelheim-venture.com
Boehringer Ingelheim Venture Fund's annual revenue is $6.8 M.
Boehringer Ingelheim Venture Fund's SIC: 28; 283
Boehringer Ingelheim Venture Fund's NAICS: 32; 325.
Boehringer Ingelheim Venture Fund has 33 employees
